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Background:  Among patients with stable angina there continues to remain uncertainty regarding the effect of percutaneous coronary interventions 
(PCI) versus medical therapy.
Objectives: To undertake a meta-analysis of randomized controlled trials (RCT’s) to inform this issue.
Sources: We electronically searched MEDLINE, EMBASE, and the Cochrane Controlled Trials Register to 2010. We identified additional studies by 
contacting experts and searching bibliographies and abstracts presented at national and international meetings.
Study Eligibility: Two reviewers independently screened citations and included studies that evaluated PCI versus medical therapy for stable 
angina. We excluded studies that evaluated patients with asymptomatic CAD, unstable angina, or recent MI. We also excluded studies solely 
addressing CABG versus medical therapy.
Data Extraction: Two reviewers extracted data on patient characteristics, study conduct, methodologic quality, and outcomes of interest. We used 
a random-effects model to pool relative risks (RR).
Results:  10 trials enrolling 6752 patients met inclusion criteria. We did not detect differences between PCI versus medical therapy for all-cause 
mortality (663 events; RR 0.97; 95% confidence interval [CI], 0.84-1.12; I2=0%), cardiovascular (CV) mortality (220 events; RR 0.92; CI, 0.72-1.18; 
I2=0%), MI (476 events; RR 1.09; CI, 0.92-1.29; I2=0%), or angina relief (1973 events; RR 1.11; CI, 0.97-1.26; I2=85%).
Limitations: We found significant statistical heterogeneity for angina relief that we could not explain.
Conclusions:  RCT data does not demonstrate a superiority of PCI or medical therapy among patients with stable angina. Given the cost 
implication, we advise against an initial strategy of PCI for patients with stable angina.
